跳至主要内容
临床试验/CTRI/2020/12/029822
CTRI/2020/12/029822招募中未知

on-Interventional Study Protocol (non-PASS) with secondary use of data To understand the characteristics, treatment patterns and outcomes in nAMD across various centers in India

ovartis Healthcare Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Newly diagnosed nAMD patients
  • Patients (male or female) aged >=50 years of age at Index date
  • Patients diagnosed with nAMD in at least one eye
  • Patients with VA/OCT assessments at both baseline, Month 12 and Month 24
  • Patients treated with intravitreal injection of anti-VEGF (received at least one anti-VEGF injection during the post-index follow-up period and at least 2 visits with OCT in between Months 0-12).
  • Patients with minimum follow-up period of 24 months. (received at least one anti-VEGF injection and at least 1 visit with OCT in between Months 13-24)

排除标准

  • Patients with dry AMD, geographic atrophy and other retinal diseases
  • Patients who were part of any other trial/ study
  • Patients undergoing additional ocular treatment along with Anti VEGF agents will be excluded.

研究者

发起方
ovartis Healthcare Pvt Ltd

相似试验